Jefferies Group LLC set a €145.00 ($159.34) price target on Bayer AG (FRA:BAYN) in a research note issued to investors on Monday, May 8th. The brokerage currently has a buy rating on the healthcare company’s stock.
Other research analysts have also issued research reports about the company. Deutsche Bank AG set a €120.00 ($131.87) price target on Bayer AG and gave the stock a buy rating in a report on Tuesday, January 17th. JPMorgan Chase & Co. reissued a buy rating on shares of Bayer AG in a research report on Thursday, January 12th. Sanford C. Bernstein set a €120.00 ($131.87) price objective on Bayer AG and gave the stock a buy rating in a research report on Wednesday, January 11th. Berenberg Bank set a €118.00 ($129.67) price objective on Bayer AG and gave the stock a buy rating in a research report on Friday, January 27th. Finally, Goldman Sachs Group Inc set a €120.00 ($131.87) price objective on Bayer AG and gave the stock a buy rating in a research report on Tuesday, January 24th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock has a consensus rating of Buy and an average target price of €115.43 ($126.84).
WARNING: This piece of content was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/05/19/bayer-ag-bayn-given-a-145-00-price-target-by-jefferies-group-llc-analysts-updated.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.